Activist investor Starboard Value is urging Becton Dickinson to sell its life sciences division, citing potential value gains. Analysts estimate a spin-off could boost the company's worth by up to 30% ...

The continued solid uptake of BD's products is expected to have driven fiscal first-quarter revenues despite transitory ...

The Financial Times reports today that an activist investor wants BD (NYSE:BDX) to sell off its Life Sciences business unit.

So if this idea of high risk and high reward doesn't suit, you might be more interested in profitable, growing companies, like Becton Dickinson (NYSE:BDX). Even if this company is fairly valued by the ...

Starboard Value has taken a stake in Becton Dickinson (BDX) and is pushing the medical technology company to sell its life sciences division, ...

Shares of Becton Dickinson and Co (NYSE: BDX) climbed 3.3% following news that activist investor Starboard Value has acquired a stake in the medical technology co ...

Becton Dickinson (BDX) rose 2.4% in premarket trading as reports surface of potential separation of its $30 billion life ...

On February 2, 2025, the cryptocurrency market witnessed notable movements in several altcoins, including Siacoin, Golem, ...

Canadian director Chris Nash won the top prize on Sunday at France's Gerardmer International Fantastic Film Festival with "In ...

Shares of Becton, Dickinson and Company (NYSE:BDX – Get Free Report) have earned an average rating of “Buy” from the seven ratings firms that are presently covering the company, MarketBeat.com reports ...